Drugs modulating the biological effects of peroxynitrite and related nitrogen species

Medicinal Research Reviews

Volumn 27, Issue 1, 2007, Pages 1-64

  Olmos, Ana ^a   Giner, Rosa M ^a   Máñez, Salvador ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antioxidants; NOS; PARP inhibitors; Peroxynitrite; Reactive nitrogen species; Tyrosine nitration

Indexed keywords

3 HYDROXYFLAVONE; ACETYLCHOLINE; ANTIOXIDANT; APIGENIN; BAICALEIN; BAICALIN; BRADYKININ; CATECHIN; CHYRSIN; COUMARIC ACID; EPICATECHIN GALLATE; FLAVONOID; GALANGIN; HEMOPROTEIN; HISTAMINE; HYDROXYBENZOIC ACID; HYDROXYETHYLQUERCETIN DERIVATIVE; KAEMPFEROL; MONOXERUTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE; NITROSOPEROXYCARBONATE; PEROXYNITRITE; PROSTAGLANDIN SYNTHASE; QUERCETIN; REACTIVE NITROGEN SPECIES; RUTOSIDE; SCAVENGER; SUBSTANCE P; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; LUNG INJURY; NEUROLOGIC DISEASE; NITRATION; NITROSYLATION; NONHUMAN; REPERFUSION INJURY; REVIEW; SYSTEMATIC REVIEW;

ANIMALS; ANTIOXIDANTS; DNA DAMAGE; FREE RADICAL SCAVENGERS; HUMANS; NITRIC OXIDE; PEROXYNITROUS ACID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 33845786975     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20065     Document Type: Review

References (270)

1. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
2. Virág L, Szabó E, Gergely P, Szabó C. Peroxynitrite-induced cytotoxicity: Mechanism and opportunities for intervention. Toxicol Lett 2003;140-141:113-124.
3. Riesenfeld EH. Tratado de química inorgánica. Barcelona: Marín; 1942. 615 p.
4. McCleverty JA. Chemistry of nitric oxide relevant to biology. Chem Rev 2004;104:403-418.
5. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 1996;271:C1424-C1437.
6. Schmidt HHHW, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, Feelisch M. No 'NO from NO synthase. Proc Natl Acad Sci USA 1996;93:14492-14497.
7. Adak S, Wang Q, Stuehr DJ. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. J Biol Chem 2000;275:33554-33561.
8. Rusche KM, Spiering MM, Marietta MA. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 1998;37:15503-15512.
9. Miranda KM, Espey MG, Yamada K, Krishna M, Ludwick N, Kim S, Jourd'heuil D, Grisham MB, Feelisch M, Fukuto JM, Wink DA. Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion. J Biol Chem 2001;276:1720-1727.
10. Feelisch M. Nitroxyl gets to the heart of the matter. Proc Natl Acad Sci USA 2003;100:4978-4980.
11. Paolocci N, Katori T, Champion HC, St. John ME, Miranda KM, Fukuto JM, Wink DA, Kass DA. Positive inotropic and lusitropic effects of HNO/NO in failing hearts: Independence from β-adrenergic signaling. Proc Natl Acad Sci USA 2003;100:5537-5542.
12. Wink DA, Miranda KM, Katori T, Mancardi D, Thomas DD, Ridnour L, Espey MG, Feelisch M, Colton CA, Fukuto JM, Pagliaro P, Kass DA, Paolocci N. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: A novel redox paradigm. Am J Physiol Heart Circ Physiol 2003;285:H2264-H2276.
13. Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Feelisch M, Fukuto JM, Wink DA. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci USA 2003;100:9196-9201.
14. Espey MG, Miranda KM, Pluta RM, Wink DA. Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem 2000;275:11341-11347.
15. Lewis RS, Tannenbaum SR, Deen WM. Kinetics of N-nitrosation in oxygenated nitric oxide solutions at physiological pH: Role of nitrous anhydride and effects of phosphate and chloride. J Am Chem Soc 1995;117:3933-3939.
16. Lewis RS, Tamir S, Tannenbaum SR, Deen WM. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J Biol Chem 1995;270:29350-29355.
17. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, De Menezes SL. Nitrogen dioxide and carbonate radical anion: Two emerging radicals in biology. Free Radic Biol Med 2002;32:841-859.
18. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-397.
19. Janssen-Heininger YM, Persinger RL, Korn SH, Pantano C, McElhinney B, Reynaert NL, Langen RC, Ckless K, Shrivastava P, Poynter ME. Reactive nitrogen species and cell signaling: Implications for death or survival of lung epithelium. Am J Respir Crit Care Med 2002;166:S9-S16.
20. Edwards JO, Plumb RC. The chemistry of peroxonitrites. In: Karlin KD, editor. Progress in inorganic chemistry. New York: J Wiley & Sons; 1994. p 599-635.
21. Kissner R, Beckman JS, Koppenol WH. Peroxynitrite studied by stopped-flow spectroscopy. Methods Enzymol 1999;301:342-352.
22. Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am J Physiol 1999;276:G315-G321.
23. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002;109:817-826.
24. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423:12-22.
25. O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: Implications for vascular disease. Circ Res 2001;88:12-21.
26. Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling. Crit Care Med 2000;28:N37-N52.
27. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268:L699-L722.
28. Meli R, Nauser T, Koppenol WH. Direct observation of intermediates in the reaction of peroxynitrite with carbon dioxide. Helv Chim Acta 1999;82:722-725.
29. Radi R, Denicola A, Freeman BA. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol 1999;301:353-367.
30. Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 1996;333: 49-58.
31. Friebe A, Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Cir Res 2003;93:96-105.
32. Kleschyov AL, Oelze M, Daiber A, Huang Y, Mollnau H, Schulz E, Sydow K, Fichtischerer B, Mulsch A, Munzel T. Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res 2003;93:e104-e112.
33. Artz JD, Schmidt B, McCracken JL, Marietta MA. Effects of nitroglycerin on soluble guanylate cyclase: Implications for nitrate tolerance. J Biol Chem 2002;277:18253-18256.
34. Denninger JW, Marietta MA. Guanylate cyclase and the 'NO/cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334-350.
35. Cairo G, Pietrangelo A. Iron regulatory proteins in pathobiology. Biochem J 2000;352:241-250.
36. Cairo G, Ronchi R, Recalcati S, Campanella A, Minotti G. Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase. Biochemistry 2002;41:7435-7442.
37. González D, Drapier JC, Bouton C. Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: Further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J Biol Chem 2004;279:43345-43351.
38. Stamler JS, Lamas S, Fang FC. Nitrosylation: The prototypic redox-based signaling mechanism. Cell 2001;106:675-683.
39. Rössig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999;274:6823-6826.
40. Park HS, Yu JW, Cho JH, Kim MS, Huh SH, Ryoo K, Choi EJ. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem 2004;279:7584-7590.
41. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: A treasure trove for drug development. Nature Rev Drug Discov 2004;3:17-26.
42. Marshall HE, Stamler JS. Inhibition of NF-κ B by S-nitrosylation. Biochemistry 2001;40:1688-1693.
43. Marshall HE, Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-κB. J Biol Chem 2002;277:34223-34228.
44. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, Janssen-Heininger YM. Nitric oxide represses inhibitory κB kinase through S-nitrosylation. Proc Natl Acad Sci USA 2004;101:8945-8950.
45. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, Kara MR, Quick RA, Cao W, O'Rourke B, Lowenstein JM, Pevsner J, Wagner DD, Lowenstein CJ. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 2003;115:139-150.
46. Gao C, Guo H, Wei J, Mi Z, Wai P, Kuo PC. S-nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages. J Biol Chem 2004;279:11236-11243.
47. Lin YF, Raab-Graham K, Jan YN, Jan LY. NO stimulation of ATP-sensitive potassium channels: Involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc Natl Acad Sci USA 2004;101:7799-7804.
48. Ischiropoulos H. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1-11.
49. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VM. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999;1411:385-400.
50. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 1998;95:7659-7663.
51. Kuhn DM, Aretha CW, Geddes TJ. Peroxynitrite inactivation of tyrosine hydroxylase: Mediation by sulfhydryl oxidation, not tyrosine nitration. J Neurosci 1999;19:10289-10294.
52. Borges CR, Geddes T, Watson JT, Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 2002;277: 48295-48302.
53. Klotz LO, Schroeder P, Sies H. Peroxynitrite signaling: Receptor tyrosine kinases and activation of stress-responsive pathways. Free Radic Biol Med 2002;33:737-743.
54. Brito C, Naviliat M, Tiscornia AC, Vuillier F, Gualco G, Dighiero G, Radi R, Cayota AM. Peroxynitrite inhibits T-lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol 1999;162:3356-3366.
55. Schopfer FJ, Baker PR, Freeman BA. NO-dependent protein nitration: A cell signaling event or an oxidative inflammatory response? Trends Biochem Sci 2003;28:646-654.
56. Birnboim HC, Lemay AM, Lam DK, Goldstein R, Webb JR. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J Immunol 2003;171:528-532.
57. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 2004;287:L262-L268.
58. Chen HJ, Chen YM, Wang TF, Wang KS, Shiea J. 8-Nitroxanthine, an adduct derived from 2′-deoxyguanosine or DNA reaction with nitryl chloride. Chem Res Toxicol 2001;14:536-546.
59. Caulfield JL, Wishnok JS, Tannenbaum SR. Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J Biol Chem 1998;273:12689-12695.
60. Bhat VB, Madyastha KM. Scavenging of peroxynitrite by phycocyanin and phycocyanobilin from Spirula platensis: Protection against oxidative damage to DNA. Biochem Biophys Res Commun 2001;285:262-266.
61. Mazzon E, Dugo L, Li JH, Di Paola R, Genovese T, Caputi AP, Zhang J, Cuzzocrea S. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochem Pharmacol 2002;64:327-337.
62. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 1995;322:339-346.
63. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med 1996;20:933-956.
64. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63:1035-1042.
65. van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 1995;214:755-759.
66. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988;37:837-841.
67. Fiala ES, Sodum RS, Bhattacharya M, Li H. (-)-Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia 1996;52:922-926.
68. Pannala A, Rice-Evans CA, Halliwell B, Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 1997;232:164-168.
69. Arteel GE, Sies H. Protection against peroxynitrite by cocoa polyphenol oligomers. FEBS Lett 1999;462:167-170.
70. Arteel GE, Schroeder P, Sies H. Reactions of peroxynitrite with cocoa procyanidin oligomers. J Nutr 2000;130:2100S-2104S.
71. Tibi S, Koppenol WH. Reactions of peroxynitrite with phenolic and carbonyl compounds: Flavonoids are not scavengers of peroxynitrite. Helv Chim Acta 2000;83:2412-2424.
72. Schroeder P, Zhang H, Klotz LO, Kalyanaraman B, Sies H. (-)-Epicatechin inhibits nitration and dimerization of tyrosine in hydrophilic as well as hydrophobic environments. Biochem Biophys Res Commun 2001;289:1334-1338.
73. Schroeder P, Klotz LO, Sies H. Amphiphilic properties of (-)-epicatechin and their significance for protection of cells against peroxynitrite. Biochem Biophys Res Commun 2003;307:69-73.
74. Ketsawatsakul U, Whiteman M, Halliwell B. A reevaluation of the peroxynitrite scavenging activity of some dietary phenolics. Biochem Biophys Res Commun 2000;279:692-699.
75. Wippel R, Rehn M, Gorren AC, Schmidt K, Mayer B. Interference of the polyphenol epicatechin with the biological chemistry of nitric oxide- and peroxynitrite-mediated reactions. Biochem Pharmacol 2004;67:1285-1295.
76. Kato Y, Ogino Y, Aoki T, Uchida K, Kawakishi S, Osawa T. Phenolic antioxidants prevent peroxynitrite-derived collagen modification in vitro. J Agric Food Chem 1997;45:3004-3009.
77. Schroeder P, Klotz LO, Buchczyk DP, Sadik CD, Schewe T, Sies H. Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun 2001;285:782-787.
78. 2 induces brain homogenate oxidation and nitration: Effects of some flavonoids. Biochim Biophys Acta 2004;1675:105-112.
79. 2. J Agric Food Chem 2004;52:2866-2874.
80. Sadowska-Krowicka H, Mannick EE, Oliver PD, Sandoval M, Zhang XJ, Eloby-Childess S, Clark DA, Miller MJS. Genistein and gut inflammation: Role of nitric oxide. Proc Soc Exp Biol Med 1998;217:351-357.
81. Boersma BJ, Patel RP, Kirk M, Jackson PL, Muccio D, Darley-Usmar VM, Barnes S. Chlorination and nitration of soy isoflavones. Arch Biochem Biophys 1999;368:265-275.
82. Pannala A, Razaq R, Halliwell B, Singh S, Rice-Evans CA. Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: Nitration or electron donation? Free Radic Biol Med 1998;24:594-606.
83. Kerry N, Rice-Evans C. Peroxynitrite oxidises catechols to o-quinones. FEBS Lett 1998;437:167-171.
84. Niwa T, Doi U, Kato Y Osawa T. Inhibitory mechanism of sinapinic acid against peroxynitrite-mediated tyrosine nitration of protein in vitro. FEBS Lett 1999;459:43-46.
85. Niwa T, Doi U, Kato Y, Osawa T. Antioxidative properties of phenolic antioxidants isolated from corn steep liquor. J Agric Food Chem 2001;49:177-182.
86. Zou Y, Kim AR, Kim JE, Choi JS, Chung HY. Peroxynitrite scavenging activity of sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) isolated from Brassica juncea. J Agric Food Chem 2002;50:5884-5890.
87. Whiteman M, Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and α1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic Res 1996;25:275-283.
88. Betancor-Fernández A, Sies H, Stahl W, Polidori MC. In vitro antioxidant activity of 2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6- hydroxychroman (α-CEHC), a vitamin E metabolite. Free Radic Res 2002; 36:915-921.
89. Olmos A, Máñez S, Giner RM, Recio MC, Ríos JL. Isoprenylhydroquinone glucoside: A new non-antioxidant inhibitor of peroxynitrite-mediated tyrosine nitration. Nitric Oxide 2005;12:54-60.
90. Chung HY, Choi HR, Park HJ, Choi JS, Choi WC. Peroxynitrite scavenging and cytoprotective activity of 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether from the marine alga Symphyocladia latiuscula. J Agric Food Chem 2001;49:3614-3621.
91. Soung do Y, Rhee SH, Kim JS, Lee JY, Yang HS, Choi JS, Yokozawa T, Han YN, Chung HY. Peroxynitrite scavenging activity of lithospermate B from Salvia miltiorrhiza. J Pharm Pharmacol 2003;55:1427-1432.
92. Soung DY, Choi HR, Kim JY, No JK, Lee JH, Kim MS, Rhee SH, Park JS, Kim MJ, Yang R, Chung HY. Peroxynitrite scavenging activity of indole derivatives: Interaction of indoles with peroxynitrite. J Med Food 2004;7:84-89.
93. Park TH, Kim DH, Kim CH, Jung HA, Choi JS, Lee JW, Chung HJ. Peroxynitrite scavenging mode of alaternin isolated from Cassia tora. J Pharm Pharmacol 2004;56:1315-1321.
94. Whiteman M, Halliwell B. Thiourea and dimethylthiourea inhibit peroxynitrite-dependent damage: Nonspecificity as hydroxyl radical scavengers. Free Rad Biol Med 1997;22:1309-1312.
95. Rose P, Widder S, Looft J, Pickenhagen W, Ong CN, Whiteman M. Inhibition of peroxynitrite-mediated cellular toxicity, tyrosine nitration, and α1-antiproteinase inactivation by 3-mercapto-2-methylpental-1-ol, a novel compound isolated from Allium cepa. Biochem Biophys Res Commun 2003;302:397-402.
96. Fontana M, Pecci L, Macone A, Cavallini D. Antioxidant properties of the decarboxylated dimer of aminoethylcysteine ketimine: Assessment of its ability to scavenge peroxynitrite. Free Rad Res 1998;29:435-440.
97. Fontana M, Pinnen F, Lucente G, Pecci L. Prevention of peroxynitrite-dependent damage by carnosine and related sulphonamido pseudodipeptides. Cell Mol Life Sci 2002;59:546-551.
98. 1- antiproteinase inactivation by oxidized and reduced lipoic acid. FEBS Lett 1996;379:74-76.
99. Nakagawa H, Sumiki E, Ikota N, Matsushima Y, Ozawa T. Endogenous and new synthetic antioxidants for peroxynitrite: Selective inhibitory effect of 5-methoxytryptamine and lipoic acid on tyrosine nitration by peroxynitrite. Antiox Redox Signal 1999;1:239-244.
100. Nakagawa H, Takusagawa M, Arima H, Furukawa K, Kinoshita T, Ozawa T, Ikota N. Selective scavenging property of the indole moiety for the nitrating species of peroxynitrite. Chem Pharm Bull 2004;52:146-149.
101. Coffey MJ, Phare SM, Peters-Golden M. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 2001;299:198-203.
102. Kuhn DM, Geddes TJ. Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide. Mol Pharmacol 2003;64:946-953.
103. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999;30:186-195.
104. Bezerra MM, Brain SD, Greenacre S, Jeronimo SM, de Melo LB, Keeble J, daRocha FA. Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis. Br J Pharmacol 2004;141:172-182.
105. Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994;16:149-156.
106. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997;1:145-157.
107. Haenen GRMM, Paquay JBG, Korthouwer REM, Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 1997;236:591-593.
108. Soung DY, Kim JS, Chung HY, Jung HA, Park JC, Choi JS. Flavonoids and chlorogenic acid from Eriobotrya japonica scavenge peroxynitrite. Nat Prod Sci 1999;5:80-84.
109. Heijnen CGM, Haenen GRMM, van Acker FAA, van der Vijgh WJF, Bast A. Flavonoids as peroxynitrite scavengers: The role of the hydroxyl groups. Toxicol In Vitro 2001;15:3-6.
110. Choi JS, Chung HY, Kang SS, Jung MJ, Kim JW, No JK, Jung HA. The structure-activity relationship of flavonoids as scavengers of peroxynitrite. Phytother Res 2002;16:232-235.
111. Paquay JBG, Haenen GRMM, Slender G, Wiseman SA, Tijburg LBM, Bast A. Protection against nitric oxide toxicity by tea. J Agric Food Chem 2000;48:5768-5772.
112. Yokozawa T, Kashiwada Y, Hattori M, Chung Y. Study on the components of Luobuma with peroxynitrite-scavenging activity. Biol Pharm Bull 2002;25:748-752.
113. Chung HY, Yokozawa T, Soung DY, Kye IS, No JK, Baek BS. Peroxynitrite-scavenging activity of green tea tannin. J Agric Food Chem 1998;46:4484-4486.
114. Choi HR, Choi JS, Han YN, Bae SJ, Chung HY. Peroxynitrite scavenging activity of herb extracts. Phytother Res 2002;16:364-367.
115. Goto Y, Watanabe N, Kogawa N, Tsuchiya M, Takahashi O, Uchi H, Furue M, Hayashi H. CX-659S: A novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities. Eur J Pharmacol 2002;438:189-196.
116. Muijsers RBR, van den Worm E, Folkerts G, Beukelman CJ, Koster AS, Postma DS, Nijkamp FP. Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol 2000;130:932-936.
117. Southan GJ, Salzman AL, Szabó C. Hydroxyguanidines inhibit peroxynitrite-induced oxidation. Free Rad Biol Med 1998;25:914-925.
118. Fernandes E, Toste SA, Lima JLFC, Reis S. The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med 2003;35:1008-1017.
119. Boveris A, Valdez L, Álvarez S. Inhibition by wine polyphenols of peroxynitrite-initiated chemiluminescence and NADH oxidation. Ann N Y Acad Sci 2002;957:90-102.
120. Van Dyke KV, McConnell P, Marquardt L. Green tea extract and its polyphenols markedly inhibit luminol-dependent chemiluminescence activated by peroxynitrite or SIN-1. Luminescence 2000;15: 37-43.
121. Kerry N, Rice-Evans C. Inhibition of peroxynitrite-mediated oxidation of dopamine by flavonoid and phenolic antioxidants and their structural relationships. J Neurochem 1999;73:247-253.
122. Drake J, Kanski J, Varadarajan S, Tsoras M, Butterfield DA. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res 2002;68:776-784.
123. Zhao CY, Shi YM, Yao SD, Jia ZJ, Fan BT, Wang WF, Lin WZ, Lin NY, Zheng RL. Scavenging effects of natural phenols on oxidizing intermediates of peroxynitrite. Pharmazie 2003;58:742-749.
124. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004;84:731-765.
125. Southan GJ, Szabó C, Thiemermann C. Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995;114:510-516.
126. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 1996;117:619-632.
127. Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 1996;118:1659-1668.
128. Szabó C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997;272:9030-9036.
129. Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabo C. Antiinflammatory effects of mercaptoethyl-guanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998;24:450-459.
130. Brahn E, Banquerigo ML, Firestein GS, Boyle DL, Salzmann AL, Szabo C. Collagen induced arthritis: Reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol 1998;25:1785-1793.
131. Zingarelli B, Cuzzocrea S, Szabó C, Salzman AL. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 1998;287:1048-1055.
132. Zingarelli B, Southan GJ, Gilad E, O'Connor M, Salzman AL, Szabó C. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Br J Pharmacol 1997;120:357-366.
133. Whiteman M, Szabó C, Halliwell B. Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of α1-antiproteinase by mercaptoethylguanidine. Br J Pharmacol 1999;126:1646-1652.
134. Whiteman M, Halliwell B. Thiols and disulphides can aggravate peroxynitrite-dependent inactivation of α1-antiproteinase. FEBS Lett 1997;414:497-500.
135. Chen XL, Li WB, Zhou AM, Ai J, Huang SS. Role of endogenous peroxynitrite in pulmonary injury and fibrosis induced by bleomycin A5 in rats. Acta Pharmacol Sin 2003;24:697-702.
136. Szabó A, Hake P, Salzman AL, Szabó C. Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med 1999;27:1343-1350.
137. Ploner F, Radermacher P, Theisen M, Tugtekin IF, Matejovic M, Stehr A, Szabó C, Southan GJ, Georgieff M, Brückner UB, Träger K. Effects of combined selective iNOS inhibition and peroxynitrite blockade during endotoxemia in pigs. Shock 2001; 16:130-136.
138. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C, Rabinovitch A. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J Autoimmun 2001;16:449-455.
139. He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W. Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem 2003;86:1338-1345.
140. Kuhn DM, Geddes TJ. Reduced nicotinamide nucleotides prevent nitration of tyrosine hydroxylase by peroxynitrite. Brain Res 2002;933:85-89.
141. Matthews RT, Yang L, Beal MF. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp Neurol 1997;143:282-286.
142. Filep JG, Beauchamp M, Baron C, Paquette Y. Peroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood. J Immunol 1998;161:5656-5662.
143. Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JG. Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 2001;69:815-824.
144. Ogiwara T, Satoh K, Negoro T, Okayasu H, Sakagami H, Fujisawa S. Inhibition of NO production by activated macrophages by phenolcarboxylic acid monomers and polymers with radical scavenging activity. Anticancer Res 2003;23:1317-1323.
145. Song YS, Park EH, Hur GM, Ryu YS, Lee YS, Lee JY, Kim YM, Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett 2002;175: 53-61.
146. Ippoushi K, Azuma K, Ito H, Horie H, Higashio H. [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sci 2003;73:3427-3437.
147. Bode AM, Ma WY, Surh YJ, Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 2001;61:850-853.
148. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995;206:533-540.
149. Yokozawa T, Chen CP, Tanaka T. Direct scavenging of nitric oxide by traditional crude drugs. Phytomedicine 2000;6:453-463.
150. Yokozawa T, Chen CP, Tanaka T, Kitani K. V. A study on the nitric oxide production-suppressing activity of sanguisorbae radix components. Biol Pharm Bull 2000;23:717-722.
151. Yokozawa T, Chen CP, Tanaka T, Kitani K. Effects of sanguiin H-6, a component of Sanguisorbae Radix, on lipopolysaccharide-stimulated nitric oxide production. Biochem Pharmacol 2002;63:853-858.
152. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: Studies with the inducible nitric oxide synthase inhibitor L-N6-(1-iminoethyl)lysine. J Pharmacol Exp Ther 2000;295:417-422.
153. Rhyu DY, Yokozawa T, Choa EJ, Park JC. Prevention of peroxynitrite- induced renal injury through modulation of peroxynitrite production by the Chinese prescription Wen-Pi-Tang. Free Radic Res 2002;36:1261-1269.
154. Imam SZ, Newport GD, Islam F, Slikker W, Jr., Ali SF. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999;818:575-578.
155. Imam SZ, Crow JP, Newport GD, Islam F, Slikker W, Jr., Ali SF. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: Protective effects of peroxynitrite decomposition catalyst. Brain Res 1999;837:15-21.
156. Imam SZ, el-Yazal J, Newport GD, Itzhak Y, Cadet JL, Slikker W, Jr., Ali SF. Methamphetamine-induced dopaminergic neurotoxicity: Role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci 2001;939:366-380.
157. Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci 2002;965:225-232.
158. Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker W, Jr., Ali SF. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: Evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem 2001;76:745-749.
159. Matata BM, Galiñanes M. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-κ DNA binding activity. J Biol Chem 2002;277:2330-2335.
160. Iho S, Tanaka Y, Takauji R, Kobayashi C, Muramatsu I, Iwasaki H, Nakamura K, Sasaki Y, Nakao K, Takahashi T. Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-κB. J Leukoc Biol 2003;74:942-951.
161. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, Thiemermann C. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002;135:496-510.
162. Briviba K, Roussyn I, Sharov VS, Sies H. Attenuation of oxidation and nitration reactions of peroxynitrite by selenomethionine, selenocystine and ebselen. Biochem J 1996;319:13-15.
163. József L, Filep JG. Selenium-containing compounds attenuate peroxynitrite-mediated NF-κB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. Free Radic Biol Med 2003;35:1018-1027.
164. Zingarelli B, Hasko G, Salzman AL, Szabó C. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Crit Care Med 1999;27:1701-1707.
165. Zingarelli B, Scott GS, Hake P, Salzman AL, Szabó C. Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation. Shock 2000;13:126-134.
166. 2 cytotoxicity by poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 2000;278:590-598.
167. Cuzzocrea S, McDonald MC, Mazzon E, Dugo L, Serraino I, Threadgill M, Caputi AP, Thiemermann C. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 2002;63:293-304.
168. Bowes J, Piper J, Thiemermann C. Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 1998;124:1760-1766.
169. Bowes J, McDonald MC, Piper J, Thiemermann C. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. Cardiovasc Res 1999;41:126-134.
170. Mazzon E, Serraino I, Li JH, Dugo L, Caputi AP, Zhang J, Cuzzocrea S. GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation. Eur J Pharmacol 2001;415:85-94.
171. Szabó C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M. Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 1997;186:1041-1049.
172. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C. Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 1998;342:67-76.
173. Southan GJ, Szabó C. Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 2003;10:321-340.
174. Jagtap P, Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005;4:421-440.
175. Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM, Sebolt-Leopold JS. Dihydroisoquinolinones: The design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Des 1991;6:107-117.
176. Arundel-Suto CM, Scavone SV, Turner WR, Suto MJ, Sebolt-Leopold JS. Effect of PD 128763, a new potent inhibitor of poly(ADP-ribose) polymerase, on X-ray-induced cellular recovery processes in Chinese hamster V79 cells. Radiat Res 1991;126:367-371.
177. McDonald MC, Mota-Filipe H, Wright JA, Abdelrahman M, Threadgill MD, Thompson AS, Thiemermann C. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 2000;130:843-850.
178. LaPlaca MC, Zhang J, Raghupathi R, Li JH, Smith F, Bareyre FM, Snyder SH, Graham DI, McIntosh TK. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma 2001;18:369-376.
179. Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, Cuzzocrea S. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 2002;17:222-227.
180. Pacher P, Liaudet L, Mabley J, Komjati K, Szabó C. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 2002;40:1006-1016.
181. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C. The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 2002;51:514-521.
182. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabo C. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 2002;9:659-664.
183. Pacher P, Cziraki A, Mabley JG, Liaudet L, Papp L, Szabó C. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 2002;64: 1785-1791.
184. Goldfarb RD, Marton A, Szabó E, Virág L, Salzman AL, Clock D, Akhter I, McCarthy R, Parrillo JE, Szabó C. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002;30:974-980.
185. Liaudet L, Pacher P, Mabley JG, Virág L, Soriano FG, Hasko G, Szabó C. Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002;165:372-377.
186. Virág L, Bai P, Bak I, Pacher P, Mabley JG, Liaudet L, Bakondi E, Gergely P, Kollai M, Szabó C. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 2004;10:BR77-BR83.
187. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabó C, Stevens MJ. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004;53:711-720.
188. Ohshima H, Yoshie Y, Auriol S, Gilibert I. Antioxidant and pro-oxidant actions of flavonoids: Effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion. Free Radic Biol Med 1998;25:1057-1065.
189. Grace SC, Salgo MG, Pryor WA. Scavenging of peroxynitrite by a phenolic/peroxidase system prevents oxidative damage to DNA. FEBS Lett 1998;426:24-28.
190. Serraino I, Dugo L, Dugo P, Mondello L, Mazzon E, Dugo G, Caputi AP, Cuzzocrea S. Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci 2003;73:1097-1114.
191. Lai HH, Yen GC. Inhibitory effect of isoflavones on peroxynitrite- mediated low-density lipoprotein oxidation. Biosci Biotech Biochem 2002;66:22-28.
192. Yen GC, Lai HH. Inhibitory effects of isoflavones on nitric oxide- or peroxynitrite-mediated DNA damage in RAW 264.7 cells and φX174 DNA. Food Chem Toxicol 2002;40:1433-1440.
193. Yen GC, Lai HH. Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts. J Agric Food Chem 2003;51:7892-7900.
194. Oldreive C, Zhao K, Paganga G, Halliwell B, Rice-Evans C. Inhibition of nitrous acid-dependent tyrosine nitration and DNA base deamination by flavonoids and other phenolic compounds. Chem Res Toxicol 1998;11:1574-1579.
195. Chen HJ, Wu SB, Chang CM. Biological and dietary antioxidants protect against DNA nitration induced by reaction of hypochlorous acid with nitrite. Arch Biochem Biophys 2003;415:109-116.
196. 9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity. Involvement of peroxynitrite. Am J Pathol 2003; 163:1997-2008.
197. Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL, Szabó C. Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol 1998;123:525-537.
198. Aruoma OI, Spencer JPE, Mahmood N. Protection against damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol 1999;37:1043-1053.
199. Aruoma OI, Whiteman M, England TG, Halliwell B. Antioxidant action of ergothioneine: Assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 1997;231:389-391.
200. Cai L, Klein JB, Kang YJ. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 2000;275:38957-38960.
201. Dugo L, Chatterjee PK, Mazzon E, McDonald MC, Paola RD, Fulia F, Caputi AP, Thiemermann C, Cuzzocrea S. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat. Intensive Care Med 2002;28:775-788.
202. Yokozawa T, Rhyu DY, Cho EJ. Protection by the Chinese prescription Wen-Pi-Tang against renal tubular LLC-PK1 cell damage induced by 3-morpholinosydnonimine. J Pharm Pharmacol 2003;55:1405-1412.
203. Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan-Koch S, Durkacz BW, Hostomsky Z, Kumpf RA, Kyle S, Li J, Maegley K, Newell DR, Notarianni E, Stratford IJ, Skalitzky D, Thomas HD, Wang LZ, Webber SE, Williams KJ, Curtin NJ. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J Natl Cancer Inst 2004;96:56-67.
204. Curtin NJ, Wang LZ, Yiakouvaki A, Kyle S, Arris CA, Canan-Koch S, Webber SE, Durkacz BW, Calvert HA, Hostomsky Z, Newell DR. Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. Clin Cancer Res 2004;10: 881-889.
205. Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 2003;63:6008-6015.
206. Veuger SJ, Curtin NJ, Smith GC, Durkacz BW. Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. Oncogene 2004;23:7322-7329.
207. Miknyoczki SJ, Jones-Bolin S, Pritchard S, Hunter K, Zhao H, Wan W, Ator M, Bihovsky R, Hudkins R, Chatterjee S, Klein-Szanto A, Dionne C, Ruggeri B. Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor. Mol Cancer Ther 2003;2:371-382.
208. Calabrese CR, Batey MA, Thomas HD, Durkacz BW, Wang LZ, Kyle S, Skalitzky D, Li J, Zhang C, Boritzki T, Maegley K, Calvert AH, Hostomsky Z, Newell DR, Curtin NJ. Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. Clin Cancer Res 2003;9:2711-2718.
209. Skalitzky DJ, Marakovits JT, Maegley K, Ekker A, Yu XH, Hostomsky Z, Webber SE, Eastman BW, Almassy R, Li J, Curtin NJ, Newell DR, Calvert AH, Griffin RJ, Golding BT. Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem 2003;46:210-213.
210. White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ, Hostomsky Z, Maegley K, Newell DR, Srinivasan S, Golding BT. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem 2000;43:4084-4097.
211. Canan Koch SS, Thoresen LH, Tikhe JG, Maegley KA, Almassy RJ, Li J, Yu XH, Zook SE, Kumpf RA, Zhang C, Boritzki TJ, Mansour RN, Zhang KE, Ekker A, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang LZ, Calvert AH, Golding BT, Griffin RJ, Newell DR, Webber SE, Hostomsky Z. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J Med Chem 2002;45:4961-4974.
212. Bowman KJ, White A, Golding BT, Griffin RJ, Curtin NJ. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br J Cancer 1998;78:1269-1277.
213. Tentori L, Portarena I, Vernole P, De Fabritiis P, Madaio R, Balduzzi A, Roy R, Bonmassar E, Graziani G. Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components. Cancer Chemother Pharmacol 2001;47:361-369.
214. Holl V, Coelho D, Weltin D, Hyun JW, Dufour P, Bischoff P. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone. Anticancer Res 2000;20:3233-3241.
215. Pacher P, Vaslin A, Benko R, Mabley JG, Liaudet L, Hasko G, Marton A, Batkai S, Kollai M, Szabo C. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther 2004;311:485-491.
216. Szabó G, Soos P, Mandera S, Heger U, Flechtenmacher C, Bahrle S, Seres L, Cziraki A, Gries A, Zsengeller Z, Vahl CF, Hagl S, Szabó C. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation. Shock 2004;21:426-432.
217. Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, Traber LD, Schmalstieg FC, Salzman AL, Mabley JG, Komjati K, Pacher P, Zsengeller Z, Szabó C, Traber DL. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004;21:126-133.
218. Shimoda K, Murakami K, Enkhbaatar P, Traber LD, Cox RA, Hawkins HK, Schmalstieg FC, Komjati K, Mabley JG, Szabó C, Salzman AL, Traber DL. Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol 2003;285:L240-L249.
219. Murthy KG, Xiao CY, Mabley JG, Chen M, Szabó C. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Shock 2004;21:230-234.
220. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997;100:723-735.
221. Sandoval M, Zhang XJ, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: Attenuation by L-ascorbic acid. Free Radic Biol Med 1997;22:489-495.
222. Virág L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL, Szabó C. Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 1998;94:345-355.
223. Virág L, Marmer DJ, Szabó C. Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation. Free Radic Biol Med 1998;25:1075-1082.
224. Yokozawa T, Chen CP, Rhyu DY, Tanaka T, Park JC, Kitani K. Potential of sanguiin H-6 against oxidative damage in renal mitochondria and apoptosis mediated by peroxynitrite in vivo. Nephron 2002;92:133-141.
225. Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R. Cytochrome c nitration by peroxynitrite. J Biol Chem 2000;275:21409-21415.
226. Kanesaki T, Saeki M, Ooi Y, Suematsu M, Matsumoto K, Sakuda M, Saito K, Maeda S. Morphine prevents peroxynitrite-induced death of human neuroblastoma SH-SY5Y cells through a direct scavenging action. Eur J Pharmacol 1999;372:319-324.
227. Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Oh J, Chung YT, Son Y, Kim BR, Park R. Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: Potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 2001; 61:779-786.
228. Wei T, Chen C, Hou J, Zhao B, Xin W, Mori A. The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells. Toxicology 1999;134:117-126.
229. Wei T, Sun H, Zhao X, Hou J, Hou A, Zhao Q, Xin W. Scavenging of reactive oxygen species and prevention of oxidative neuronal cell damage by a novel gallotannin, pistafolia A. Life Sci 2002;70:1889-1899.
230. Salgo MG, Pryor WA. Trolox inhibits peroxynitrite-mediated oxidative stress and apoptosis in rat thymocytes. Arch Biochem Biophys 1996;333:482-488.
231. Virág L, Szabó C. Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation. Br J Pharmacol 1999;126:769-777.
232. Virág L, Szabó C. Purines inhibit poly(ADP-ribose) polymerase activation and module oxidant-induced cell death. FASEB J 1999;1:99-107.
233. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-159.
234. Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, Salvemini D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 2000;14:1061-1072.
235. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 1999;127:685-692.
236. Mabley JG, Liaudet L, Pacher P, Southan GJ, Salzman AL, Szabó C. Part II: Beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med 2002;8:581-590.
237. Szabó C, Mabley JG, Moeller SM, Shimanovich R, Pacher P, Virág L, Soriano FG, Van Duzer JH, Williams W, Salzman AL, Groves JT. Part I: Pathogenetic role of peroxynitrite in the development of diabetic vascular complications: Studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 2002;8:571-580.
238. Naidu BV, Farivar AS, Woolley SM, Fraga C, Salzman AL, Szabo C, Groves JT, Mulligan MS. Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. Exp Mol Pathol 2003;75:12-17.
239. Bianchi C, Wakiyama H, Faro R, Khan T, McCully JD, Levitsky S, Szabó C, Sellke FW. A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs. Ann Thorac Surg 2002;74:1201-1207.
240. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virág L, Deb A, Szabó E, Ungvári Z, Wolin MS, Groves JT, Szabó C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 2003;107:896-904.
241. Bonini MG, Mason RP, Augusto O. The mechanism by which 4-hydroxy-2,2,6,6-tetramethylpiperidene-1-oxyl (tempol) diverts peroxynitrite decomposition from nitrating to nitrosating species. Chem Res Toxicol 2002;15:506-511.
242. Mierzwa S, Chan SK. Chemical modification of human α1-proteinase inhibitor by tetranitromethane. Biochem J 1987;246:37-42.
243. Moreno JJ, Pryor WA. Inactivation of alpha 1-proteinase inhibitor by peroxynitrite. Chem Res Toxicol 1992;5:425-431.
244. Whiteman M, Kaur H, Halliwell B. Protection against peroxynitrite dependent tyrosine nitration and α1-antiproteinase inactivation by some anti-inflammatory drugs and by the antibiotic tetracycline. Ann Rheum Dis 1996;55:383-387.
245. Lee CS, Jang YY, Song JS, Song JH, Han ES. Ambroxol inhibits peroxynitrite-induced damage of α1-antiproteinase and free radical production in activated phagocytic cells. Pharmacol Toxicol 2002;91:140-149.
246. Cheung PY, Danial H, Jong J, Schulz R. Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys 1998;350:104-108.
247. Tannenbaum SR, Wishnok JS, Leaf CD. Inhibition of nitrosamine formation by ascorbic acid. Am J Clin Nutr 1991;53:247S-250S.
248. Kono Y, Shibata H, Kodama Y, Sawa Y. The suppression of the N-nitrosating reaction by chlorogenic acid. Biochem J 1995;312:947-953.
249. Shi H, Noguchi N, Xu Y, Niki E. Formation of phospholipid hydroperoxides and its inhibition by α-tocopherol in rat brain synaptosomes induced by peroxynitrite. Biochem Biophys Res Commun 1999;257:651-656.
250. Hermann M, Kapiotis S, Hofbauer R, Exner M, Seelos C, Held I, Gmeiner B. Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals. FEBS Lett 1999;445:212-214.
251. Kostyuk VA, Kraemer T, Sies H, Schewe T. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulatedby flavonoids. FEBS Lett 2003;537:146-150.
252. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK. Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease. J Immunol 2004;172:5790-5798.
253. Jones AB. Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond. Med Res Rev 2001;21:540-552.
254. Crosby MB, Svenson JL, Zhang J, Nicol CJ, Gonzalez FJ, Gilkeson GS. Peroxisome proliferation-activated receptor (PPAR)γ is not necessary for synthetic PPARγ agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther 2005;312:69-76.
255. 2 on bleomycin-induced lung injury. Eur Respir J 2005;25:225-234.
256. Shiojiri T, Wada K, Nakajima A, Katayama K, Shibuya A, Kudo C, Kadowaki T, Mayumi T, Yura Y, Kamisaki Y. PPARγ ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur J Pharmacol 2002;448:231-238.
257. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002;33:1451-1464.
258. Packer MA, Murphy MP. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett 1994;345:237-240.
259. Lin D, Takemoto DJ. Oxidative activation of protein kinase Cγ through the C1 domain: Effects on gap junctions. J Biol Chem 2005;280:13682-13693.
260. Schieke SM, Briviba K, Klotz LO, Sies H. Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: Attenuation by selenite supplementation. FEBS Lett 1999;448:301-303.
261. Sharov VS, Briviba K, Sies H. Peroxynitrite diminishes gap junctional communication: Protection by selenite supplementation. IUBMB Life 1999;48:379-384.
262. Fici GJ, Althaus JS, Von Voigtlander PF. Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity. Free Radic Biol Med 1997;22:223-228.
263. Rohn TT, Quinn MT. Inhibition of peroxynitrite-mediated tyrosine nitration by a novel pyrrolopyrimidine antioxidant. Eur J Pharmacol 1998;353:329-336.
264. Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 2004;11:89-97.
265. Rubbo H, O'Donnell V. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: Mechanism insights. Toxicology 2005;208:305-317.
266. Boscà L, Zeini M, Traves PG, Hortelano S. Nitric oxide and cell viability in inflammatory cells: A role for NO in macrophage function and fate. Toxicology 2005;208:249-258.
267. Casella L, Monzani E, Roncone R, Nicolis S, Sala A, De Riso A. Formation of reactive nitrogen species at biologic heme centers: A potential mechanism of nitric oxide-dependent toxicity. Environ Health Perspect 2002;110:709-711.
268. Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin. Oncogene 2005;24:2558-2567.
269. Máñez S, Recio MC. Modulation of protein phosphorylation by natural products. In: Atta-Ur-Rahman AU, editor. Studies in Natural Products Chemistry: Bioactive Natural Products. Amsterdam: Elsevier; 2002. p 819-890.
270. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, Chopin C, Neviere R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 2004;43:2348-2358.